Synergia Medical

Synergia Medical is a startup founded in 2014 by Pascal Doguet and Attila Borbath, specializing in innovative medical devices for neurostimulation applications. The company is developing a neuromodulation platform called NAO, which aims to enhance existing neural stimulation therapies by eliminating metal components. This approach addresses challenges related to electromagnetic interference (EMI), improving safety and reliability for patients. The NAO platform includes the NAOS, an optoelectronic neurostimulator designed for treating drug-resistant epilepsy and other neurological disorders. This device has received approval from Belgian health authorities to begin first-in-human clinical studies. Synergia Medical is also working on a pipeline of at least five additional medical devices targeting nervous system and respiratory tract diseases, utilizing advanced technology such as glass encapsulation and plastic optical fibers to ensure precise and interference-free therapy delivery. The company aims to serve patients with neurological disorders and healthcare providers specializing in neurology, aspiring to become a key player in the neurostimulation field by offering safer and more effective treatment options.

• Employees 20
• Founded 2013
• Total Funding $23202835